Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

379 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
On the origin of (CD105+) circulating endothelial cells.
Strijbos MH, Verhoef C, Gratama JW, Sleijfer S. Strijbos MH, et al. Among authors: sleijfer s. Thromb Haemost. 2009 Aug;102(2):347-51. doi: 10.1160/TH08-11-0762. Thromb Haemost. 2009. PMID: 19652886
Process validation and clinical evaluation of a protocol to generate gene-modified T lymphocytes for imunogene therapy for metastatic renal cell carcinoma: GMP-controlled transduction and expansion of patient's T lymphocytes using a carboxy anhydrase IX-specific scFv transgene.
Lamers CH, van Elzakker P, Langeveld SC, Sleijfer S, Gratama JW. Lamers CH, et al. Among authors: sleijfer s. Cytotherapy. 2006;8(6):542-53. doi: 10.1080/14653240601056396. Cytotherapy. 2006. PMID: 17148030
Circulating endothelial cells in oncology: pitfalls and promises.
Strijbos MH, Gratama JW, Kraan J, Lamers CH, den Bakker MA, Sleijfer S. Strijbos MH, et al. Among authors: sleijfer s. Br J Cancer. 2008 Jun 3;98(11):1731-5. doi: 10.1038/sj.bjc.6604383. Epub 2008 May 27. Br J Cancer. 2008. PMID: 18506173 Free PMC article. Review.
Decrease of CD117 expression as possible prognostic marker for recurrence in the resected specimen after imatinib treatment in patients with initially unresectable gastrointestinal stromal tumors: a clinicopathological analysis.
Mearadji A, den Bakker MA, van Geel AN, Eggermont AM, Sleijfer S, Verweij J, de Wilt JH, Verhoef C. Mearadji A, et al. Among authors: sleijfer s. Anticancer Drugs. 2008 Jul;19(6):607-12. doi: 10.1097/CAD.0b013e32830138f9. Anticancer Drugs. 2008. PMID: 18525320
379 results